Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain
- 1 September 1994
- journal article
- Published by Wolters Kluwer Health
- Vol. 58 (3) , 355-66
- https://doi.org/10.1016/0304-3959(94)90130-9
Abstract
Nst chronic nociception. Rats display preferences for environments that have been previously paired with positively reinforcing drugs; whether place preference to the negatively reinforcing effects of analgesic drugs in an animal model of chronic pain occurs is yet unknown. The present research sought to determine whether animals experiencing chronic pain would display a place preference for an environment paired with analgesic drug treatment. Persistent inflammatory nociception was induced by unilateral injections of complete Freund's adjuvant (0.1 ml) into the rat hind paw. Place preference to the opiate agonist morphine, the Symbol (NMDA) receptor antagonist MK-801 and the non-steroidal anti-inflammatory drug (NSAID) indomethacin was examined in 3 separate experiments. Rats received 8 counterbalanced conditioning trials (4 drug, 4 no-drug) of 60 min each with various drug doses (morphine: 3.0 and 10.0 mg/kg; indomethacin: 2.5 and 5.0 mg/kg; MK-801: 0.03, 0.1 and 0.3 mg/kg i.p.) or vehicle serving as the reinforcing stimuli in a 3 compartment (2 stimuli, 1 neutral) place preference apparatus. In general, morphine place preference was observed in both inflamed and non-inflamed groups; inflamed groups exhibited enhanced morphine place preference than non-inflamed groups. MK-801 produced a low-dose place preference in inflamed animals; higher doses of MK-801 produced a place aversion in both inflamed and non-inflamed groups. Indomethacin failed to produced place preference in either inflamed or non-inflamed groups. These data demonstrate that the negatively reinforcing properties of analgesic drugs can be assessed via the CPP paradigm. In addition, this paradigm offers greater clinical relevance as animals determine drug efficacy without the involvement of high-intensity, phasic nociceptive stimulation. JOURNAL/jpain/04.03/00006396-199409000-00008/figure1-8/v/2021-01-12T070624Z/r/image-png ∗Corresponding author: K.J. Sufka, Ph.D., 301 Peabody Building, University of Mississippi, Oxford MS 38677, USA. FAX: (601) 232-5398. (Received 12 July 1993; revision received 11 January 1994; accepted 16 February 1994.) © Lippincott-Raven Publishers....Keywords
This publication has 42 references indexed in Scilit:
- The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injuryJournal of Neuroscience, 1992
- A limited arthritic model for chronic pain studies in the ratPain, 1992
- Effects of apomorphine on novelty-induced place preference behavior in ratsPharmacology Biochemistry and Behavior, 1990
- The role of descending inhibition in morphine-induced analgesiaTrends in Pharmacological Sciences, 1988
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agentsPharmacology Biochemistry and Behavior, 1988
- Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freundʼs adjuvantPain, 1987
- Evidence that adjuvant arthritis in the rat is associated with chronic painPain, 1987
- Single-trial conditioned place preference using intravenous morphinePharmacology Biochemistry and Behavior, 1986
- Morphine analgesia in the tail-flick and Formalin pain tests is mediated by different neural systemsExperimental Neurology, 1982